New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
14:35 EDTMNK, ACTActavis' generic version of Exalgo approved by FDA
The FDA approved Actavisí (ACT) generic version of hydromorphone hydrochloride in strengths of 8 mg, 12 mg and 16 mg on May 12, according to a post to the FDA website. Hydromorphone hydrochloride is sold in branded form under the name Exalgo by Mallinckrodt (MNK). Reference Link
News For MNK;ACT From The Last 14 Days
Check below for free stories on MNK;ACT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
13:13 EDTMNKEinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
12:18 EDTMNKGreenlight discloses short positions in Safeway, Questcor, Bloomberg says
Subscribe for More Information
July 23, 2014
10:02 EDTMNK, ACTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTMNK, ACTDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTACTActavis initiated with a Buy at Deutsche Bank
Subscribe for More Information
16:09 EDTMNKMallinckrodt initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
16:36 EDTACTActavis and Medicines360 announce FDA acceptance of Levosert NDA
Subscribe for More Information
07:36 EDTMNKMallinckrodt price target raised to $95 from $85 at Jefferies
Subscribe for More Information
July 17, 2014
15:42 EDTACTDepomed says Actavis preliminarily enjoined from marketing generic Gralise
Subscribe for More Information
10:00 EDTMNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
July 16, 2014
16:13 EDTMNKMallinckrodt initiated with an Outperform, $100 target at Oppenheimer
Oppenheimer believes Mallinckrodt's (MNK) acquisition of Questcor (QCOR) provides sustainable high-growth revenue potential. It believes the company bought Acthar at an attractive valuation. Opco started shares of Mallinckrodt with an Outperform rating and $100 price target.
16:09 EDTMNKMallinckrodt initiated with an Outperform at Oppenheimer
Target $100.
11:28 EDTACTLeon Cooperman gives 12 stock picks at CNBC conference
Subscribe for More Information
11:16 EDTACTCooperman lists Actavis, Citigroup, KKR among top-picks, CNBC says
Subscribe for More Information
09:12 EDTACTLeerink healthcare analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use